Update on the pathophysiology of liver fibrosis

References

• Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet349, 825–832 (1997).
   PubMed Web of Science ®Google Scholar
• Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis.36, 231–242 (2004).
   PubMedGoogle Scholar
• Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology134, 1655–1669 (2008).
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J. Clin. Invest.115(2), 209–218 (2005).
   PubMed Web of Science ®Google Scholar
• Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest.117, 524–529 (2007).
   PubMed Web of Science ®Google Scholar
• Wake K. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int. Rev. Cytol.66, 303–353 (1980).
   PubMedGoogle Scholar
• Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin. Liver Dis.21, 351–372 (2001).
   PubMed Web of Science ®Google Scholar
• Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J. Hepatol.37, 527–535 (2002).
   PubMed Web of Science ®Google Scholar
• Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med.1, 71–81 (1994).
   PubMed Web of Science ®Google Scholar
• Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr. Rheumatol. Rep.8, 145–150 (2006).
   PubMedGoogle Scholar
• Brittan M, Hunt T, Jeffery R et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut50, 752–757 (2002).
   PubMed Web of Science ®Google Scholar
• Russo FP, Alison MR, Bigger BW et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology130, 1807–1821 (2006).
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Uchinami H, Feirt N et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol.45, 429–438 (2006).
   PubMed Web of Science ®Google Scholar
• Kalluri R, Neilson EG. Epithelial–mesenchymal transition and its implications for fibrosis. J. Clin. Invest.112, 1776–1784 (2003).
   PubMed Web of Science ®Google Scholar
• Willis BC, du Bois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc.3, 377–382 (2006).
   PubMedGoogle Scholar
• Zeisberg EM, Tarnavski O, Zeisberg M et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med.13, 952–961 (2007).
   PubMed Web of Science ®Google Scholar
• Choi SS, Diehl AM. Epithelial-to-mesenchymal transition in the liver. Hepatology50, 2007–2013 (2009).
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Yang C, Martino M et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem.282, 23337–23347 (2007).
   PubMed Web of Science ®Google Scholar
• Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J. Biol. Chem.282, 22089–22101 (2007).
   PubMed Web of Science ®Google Scholar
• Omenetti A, Yang L, Li YX et al. Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation. Lab. Invest.87, 499–514 (2007).
   PubMed Web of Science ®Google Scholar
• Omenetti A, Porrello A, Jung Y et al. Hedgehog signaling regulates epithelial–mesenchymal transition during biliary fibrosis in rodents and humans. J. Clin. Invest.118, 3331–3342 (2008).
   PubMed Web of Science ®Google Scholar
• Rygiel KA, Robertson H, Marshall HL et al. Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab. Invest.88, 112–123 (2008).
   PubMed Web of Science ®Google Scholar
• Taura K, Miura K, Iwaisako K et al. Hepatocytes do not undergo epithelial–mesenchymal transition in liver fibrosis in mice. Hepatology51, 1027–1036 (2009).
   Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N. Tissue renewal and repair: regeneration, healing, and fibrosis. In: Pathologic Basis of Disease. Kumar V, Abbas AK, Fausto N (Eds). Elsevier Saunders, PA, USA, 87–118 (2005).
   Google Scholar
• Wynn TA. Cellular and molecular mechanisms of fibrosis. J. Pathol.214, 199–210 (2008).
   Google Scholar
• Calvaruso V, Maimone S, Gatt A et al. Coagulation and fibrosis in chronic liver disease. Gut57, 1722–1727 (2008).
   PubMed Web of Science ®Google Scholar
• Marra F. Chemokines in liver inflammation and fibrosis. Front. Biosci.7, d1899–d1914 (2002).
   PubMed Web of Science ®Google Scholar
• Karlmark KR, Wasmuth HE, Trautwein C, Tacke F. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev. Gastroenterol. Hepatol.2(2), 233–242 (2008).
   PubMedGoogle Scholar
• Bataller R, Schwabe RF, Choi YH et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest.112, 1383–1394 (2003).
   PubMed Web of Science ®Google Scholar
• Oakley F, Teoh V, Ching-A-Sue G et al. Angiotensin II activates ikb kinase phosphorylation of RelA at Ser(536) to promote myofibroblast survival and liver fibrosis. Gastroenterology136, 2334–2344 (2009).
   PubMed Web of Science ®Google Scholar
• Pinzani M. Unraveling the spider web of hepatic stellate cell apoptosis. Gastroenterology136, 2061–2063 (2009).
   PubMed Web of Science ®Google Scholar
• Novo E, Marra F, Zamara E et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut55, 1174–1182 (2006).
   PubMed Web of Science ®Google Scholar
• Moreno M, Gonzalo T, Kok RJ et al. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology51(3), 942–952 (2010).
   PubMed Web of Science ®Google Scholar
• Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair1, 5 (2008).
   PubMedGoogle Scholar
• Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH. Therapy of NAFLD: antioxidants and cytoprotective agents. J. Clin. Gastroenterol.40, S51–S60 (2006).
   PubMed Web of Science ®Google Scholar
• De Alwis NMW, Day CP. Non-alcoholic fatty liver: the mist gradually clear. J. Hepatol.48, S105–S112 (2008).
   Google Scholar
• Sokol RJ, McKim JM Jr, Goff MC et al. Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology114(1), 164–174 (1998).
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Dahl R, Devereaux MW, Yerushalmi B, Kobak GE, Gumpricht E. Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids. J. Pediatr. Gastroenterol. Nutr.41(2), 235–243 (2005).
   PubMed Web of Science ®Google Scholar
• Serviddio G, Pereda J, Pallardó FV et al. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology39(3), 711–720 (2004).
   PubMed Web of Science ®Google Scholar
• Mitchell C, Robin MA, Mayeuf A et al. Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am J. Pathol.175(5), 1929–1937 (2009).
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Chalasani N, Kowdley KV. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med.362(18), 1675–1685 (2010).
   PubMed Web of Science ®Google Scholar
• Arseneau KO, Tamagawa H, Pizarro TT, Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr. Gastroenterol. Rep.9, 508–512 (2007).
   PubMedGoogle Scholar
• Meneghin MD, Hogaboam C. Infectious disease, the innate immune response, and fibrosis. J. Clin. Invest.117, 530–538 (2007).
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol.4(7), 499–511 (2004).
   PubMed Web of Science ®Google Scholar
• Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology124(7), 1866–1878 (2003).
   PubMed Web of Science ®Google Scholar
• Coelho AL, Hogaboam CM, Kunkel SL. Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev.16, 553–560 (2005).
   PubMed Web of Science ®Google Scholar
• Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol.289, G571–G578 (2005).
   Web of Science ®Google Scholar
• Brun P, Castagliuolo I, Di Leo V et al. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol.292, G518–G525 (2007).
   PubMed Web of Science ®Google Scholar
• Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology48, 322–335 (2008).
   PubMed Web of Science ®Google Scholar
• Seki E, De Minicis S, Osterreicher CH et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med.13, 1324–1332 (2007).
   PubMed Web of Science ®Google Scholar
• Huang H, Shiffman ML, Friedman S et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology46, 297–306 (2007).
   PubMed Web of Science ®Google Scholar
• Li Y, Chang M, Abar O et al. Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J. Hepatol.51, 750–757 (2009).
   PubMed Web of Science ®Google Scholar
• Watanabe A, Hashmi A, Gomes DA et al. Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll like receptor 9. Hepatology46, 1509–1518 (2007).
   PubMed Web of Science ®Google Scholar
• Gabele E, Muhlbauer M, Dorn C et al. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem. Biophys. Res. Commun.376, 271–276 (2008).
   PubMed Web of Science ®Google Scholar
• Miura K, Kodama Y, Inokuchi S et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1b in mice. Gastroenterology DOI: 10.1053/j.gastro.2010.03.052 (2010) (Epub ahead of print).
   Google Scholar
• Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut58, 704–720 (2009).
   PubMed Web of Science ®Google Scholar
• Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J. Leukoc. Biol.86(3), 513–528 (2009).
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology44(6), 1441–1451 (2006).
   PubMed Web of Science ®Google Scholar
• Melhem A, Muhanna N, Bishara A et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J. Hepatol.45(1), 60–71 (2006).
   PubMed Web of Science ®Google Scholar
• Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-g contributes to alcohol acceleration of liver fibrosis. Gastroenterology134(1), 248–258 (2008).
   PubMed Web of Science ®Google Scholar
• Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology130(2), 435–452 (2006).
   PubMed Web of Science ®Google Scholar
• Chen Y, Wei H, Sun R, Dong Z, Zhang J, Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D–ligand interaction and natural killer cells. Hepatology46(3), 706–715 (2007).
   PubMed Web of Science ®Google Scholar
• Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y. Amelioration of hepatic fibrosis via β-glucosylceramide mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int. Immunol.19, 1021–1029 (2007).
   PubMed Web of Science ®Google Scholar
• Kimura K, Nagaki M, Matsuura T, Moriwaki H, Kakimi K. Pathological role of CD44 on NKT cells in carbon tetrachloride-mediated liver injury. Hepatol. Res.39, 93–105 (2009).
   PubMed Web of Science ®Google Scholar
• Park O, Jeong WI, Wang L et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology49, 1683–1694 (2009).
   PubMed Web of Science ®Google Scholar
• Connolly MK, Bedrosian AS, Mallen-St Clair J et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-a. J. Clin. Invest.119(11), 3213–3225 (2009).
   PubMed Web of Science ®Google Scholar
• Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology126(2), 529–540 (2004).
   PubMed Web of Science ®Google Scholar
• Mazzocca A, Sciammetta SC, Carloni V et al. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J. Biol. Chem.280(12), 11329–11339 (2005).
   PubMed Web of Science ®Google Scholar
• Bruno R, Galastri S, Sacchi P et al. The HIV envelope protein GP120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut59(4), 513–520 (2010).
   PubMed Web of Science ®Google Scholar
• Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine–adipokine interplay and regulation of insulin resistance. Gastroenterology131, 934–945 (2006).
   PubMed Web of Science ®Google Scholar
• Marra F, Aleffi S, Bertolani C, Petrai I, Vizzutti F. Adipokines and liver fibrosis. Eur. Rev. Med. Pharmacol. Sci.9(5), 279–284 (2005).
   PubMedGoogle Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature372, 425–432 (1994).
   PubMed Web of Science ®Google Scholar
• Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem. Biophys. Res. Commun.244, 178–182 (1998).
   PubMed Web of Science ®Google Scholar
• Ikejima K, Honda H, Yoshikawa M et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology34, 288–297 (2001).
   PubMed Web of Science ®Google Scholar
• Honda H, Ikejima K, Hirose M et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology36, 12–21 (2002).
   PubMed Web of Science ®Google Scholar
• Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology35, 762–771 (2002).
   PubMed Web of Science ®Google Scholar
• Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J. Pathol.166, 1655–1669 (2005).
   PubMed Web of Science ®Google Scholar
• Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol.37, 206–213 (2002).
   PubMed Web of Science ®Google Scholar
• Potter JJ, Mezey E. Leptin deficiency reduces but does not eliminate the development of hepatic fibrosis in mice infected with Schistosoma mansoni. Liver22, 173–177 (2002).
   PubMedGoogle Scholar
• Bugianesi E, Manzini P, D’Antico S et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology39, 179–187 (2004).
   PubMed Web of Science ®Google Scholar
• Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol.42, 132–138 (2005).
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature409, 307–312 (2001).
   PubMed Web of Science ®Google Scholar
• Bertolani C, Sancho-Bru P, Failli P et al. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J. Pathol.169(6), 2042–2053 (2006).
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med.3, 35–42 (2006).
   PubMedGoogle Scholar
• Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest.112, 91–100 (2003).
   PubMed Web of Science ®Google Scholar
• Kamada Y, Tamura S, Kiso S et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology125, 1796–1807 (2003).
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med.8, 1288–1295 (2002).
   PubMed Web of Science ®Google Scholar
• Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology144, 5179–5183 (2003).
   PubMed Web of Science ®Google Scholar
• Caligiuri A, Bertolani C, Guerra CT et al. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology47(2), 668–676 (2008).
   PubMed Web of Science ®Google Scholar
• Caraceni P, Domenicali M, Giannone F, Bernardi M. The role of the endocannabinoid system in liver diseases. Best Pract. Res. Clin. Endocrinol. Metab.23(1), 65–77 (2009).
   PubMed Web of Science ®Google Scholar
• Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J. Gastroenterol.14(40), 6109–6114 (2008).
   PubMed Web of Science ®Google Scholar
• Siegmund SV, Shwabe RF. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol.294, G357–G362 (2008).
   Google Scholar
• Teixeira-Clerc F, Julien B, Grenard P et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med.12, 671–676 (2006).
   PubMed Web of Science ®Google Scholar
• Julien B, Grenard P, Texeira-Clerc F et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology128, 742–755 (2005).
   PubMed Web of Science ®Google Scholar
• Munoz-Luque J, Ros J, Fernandez-Varo G et al. Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J. Pharmacol. Exp. Ther.324, 475–483 (2008).
   PubMed Web of Science ®Google Scholar
• Hézode C, Zafrani ES, Roudot-Thoraval F et al. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology134(2), 432–439 (2008).
   PubMed Web of Science ®Google Scholar
• Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest.115, 56–65 (2005).
   PubMed Web of Science ®Google Scholar
• Fallowfield JA, Mizuno M, Kendall TJ et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol.178, 5288–5295 (2007).
   PubMed Web of Science ®Google Scholar
• Mitchell C, Couton D, Couty JP et al. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am. J. Pathol.174, 1766–1775 (2009).
   PubMed Web of Science ®Google Scholar
• Pesce JT, Ramalingam TR, Mentink-Kane MM et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog.5(4), e1000371 (2009).
   PubMed Web of Science ®Google Scholar
• Thompson RW, Pesce JT, Ramalingam T. Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog.4(3), e1000023 (2008).
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med.6, 389–395 (2000).
   PubMed Web of Science ®Google Scholar
• Medina J, Arroyo AG, Sanchez-Madrid F, Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology39, 1185–1195 (2004).
   PubMed Web of Science ®Google Scholar
• Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol.36, 200–209 (2002).
   PubMed Web of Science ®Google Scholar
• Corpechot C, Barbu V, Wendum D et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology35, 1010–1021 (2002).
   PubMed Web of Science ®Google Scholar
• Yoshiji H, Kuriyama S, Yoshii J et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut52, 1347–1354 (2003).
   PubMed Web of Science ®Google Scholar
• Medina J, Caveda L, Sanz-Cameno P et al. Hepatocyte growth factor activates endothelial pro-angiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. J. Hepatol.38, 660–667 (2003).
   PubMed Web of Science ®Google Scholar
• Shimoda K, Mori M, Shibuta K, Banner B, Barnard G. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma. Int. J. Oncol.14, 353–359 (1999).
   PubMed Web of Science ®Google Scholar
• Medina J, Sanz-Cameno P, Garcia-Buey L, Martin-Vilchez S, Lopez-Cabrera M, Moreno-Otero R. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J. Hepatol.42, 124–131 (2005).
   PubMedGoogle Scholar
• DeLeve LD, Wang X, Hu L, McCuskey MK, McCuskey RS. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am. J. Physiol. Gastrointest. Liver Physiol.287, G757–G763 (2004).
   PubMed Web of Science ®Google Scholar
• Novo E, Cannito S, Zamara E et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am. J. Pathol.170(6), 1942–1953 (2007).
   PubMed Web of Science ®Google Scholar
• Aleffi S, Petrai I, Bertolani C et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology42, 1339–1348 (2005).
   PubMed Web of Science ®Google Scholar
• Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinium collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology15, 599–602 (1992).
   PubMed Web of Science ®Google Scholar
• Hayasaka A, Ilda S, Suzuki N, Kondo F, Miyazaki M, Yonemitsu H. Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis. J. Hepatol.24, 692–698 (1996).
   PubMed Web of Science ®Google Scholar
• Issa R, Zhou X, Constandinou CM et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology126, 1795–1808 (2004).
   PubMed Web of Science ®Google Scholar
• Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest.117(3), 539–548 (2007).
   PubMed Web of Science ®Google Scholar
• Mallet V, Gilgenkrantz H, Serpaggi J et al. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann. Intern. Med.149(6), 399–403 (2008).
   PubMed Web of Science ®Google Scholar